Collaboration with Suzhou Municipal Hospital to establish Suzhou's first US-China dual-reporting base.

Suzhou Industrial Research Institute, Shaxi Town People's Government of Taicang City and Taicang Biomedical Industrial Park Management Committee and other governmental supporting capitals, in order to enhance the capacity building of the clinical institutions in the Suzhou local area, and to promote the accelerated development of the local enterprises' innovation, jointly established with the company the "Clinical Pharmacology Technology Research Institute of Suzhou Industrial Research Institute".

The company signed a strategic cooperation with Qingfeng Pharmaceutical Group to help Qingfeng Pharmaceutical's generic and new drug clinical advancement work through the co-establishment of hospital resources.

The company was selected as "Suzhou Industrial Park Gazelle Enterprise Cultivation Project".

The platform of the first phase I clinical research center outside the province was built successfully and formal experiments were carried out.

Suzhou's Third Co-construction Centre - Phase I Clinical Trial Research Laboratory of Suzhou Municipal Hospital Passes Recordal Records.

The company was selected as "National High-tech Enterprise".

The second co-built centre in Suzhou - Phase I Clinical Trial Research Laboratory of Suzhou No. 5 People's Hospital passes the record.

The first BE project of Suzhou Science and Technology City Hospital, the first co-construction centre in Suzhou, passed the verification.